Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP682191.RASANS65Y7dHNYMqzFJkIijMGyIFzQuoNmh0hdql9VkQA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP682191.RASANS65Y7dHNYMqzFJkIijMGyIFzQuoNmh0hdql9VkQA130_assertion type Assertion NP682191.RASANS65Y7dHNYMqzFJkIijMGyIFzQuoNmh0hdql9VkQA130_head.
- NP682191.RASANS65Y7dHNYMqzFJkIijMGyIFzQuoNmh0hdql9VkQA130_assertion description "[A significant reduction in MeCP2 expression compared to age-matched controls was found in 11/14 autism (79%), 9/9 RTT (100%), 4/4 Angelman syndrome (100%), 3/4 Prader-Willi syndrome (75%), 3/5 Down syndrome (60%), and 2/2 attention deficit hyperactivity disorder (100%) frontal cortex samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP682191.RASANS65Y7dHNYMqzFJkIijMGyIFzQuoNmh0hdql9VkQA130_provenance.
- NP682191.RASANS65Y7dHNYMqzFJkIijMGyIFzQuoNmh0hdql9VkQA130_assertion evidence source_evidence_literature NP682191.RASANS65Y7dHNYMqzFJkIijMGyIFzQuoNmh0hdql9VkQA130_provenance.
- NP682191.RASANS65Y7dHNYMqzFJkIijMGyIFzQuoNmh0hdql9VkQA130_assertion SIO_000772 17486179 NP682191.RASANS65Y7dHNYMqzFJkIijMGyIFzQuoNmh0hdql9VkQA130_provenance.
- NP682191.RASANS65Y7dHNYMqzFJkIijMGyIFzQuoNmh0hdql9VkQA130_assertion wasDerivedFrom befree-20140225 NP682191.RASANS65Y7dHNYMqzFJkIijMGyIFzQuoNmh0hdql9VkQA130_provenance.
- NP682191.RASANS65Y7dHNYMqzFJkIijMGyIFzQuoNmh0hdql9VkQA130_assertion wasGeneratedBy ECO_0000203 NP682191.RASANS65Y7dHNYMqzFJkIijMGyIFzQuoNmh0hdql9VkQA130_provenance.